ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683,622 | -46.1% | 227,874 | -32.8% | 0.00% | – |
| Q2 2023 | $1,268,178 | +104.1% | 339,085 | +82.8% | 0.00% | – |
| Q1 2023 | $621,281 | -79.4% | 185,457 | -70.4% | 0.00% | -100.0% |
| Q4 2022 | $3,013,965 | -16.4% | 626,604 | -1.1% | 0.00% | 0.0% |
| Q3 2022 | $3,604,000 | -11.1% | 633,320 | +10.9% | 0.00% | 0.0% |
| Q2 2022 | $4,053,000 | +127.4% | 570,816 | +131.4% | 0.00% | – |
| Q1 2022 | $1,782,000 | -74.6% | 246,709 | -68.6% | 0.00% | – |
| Q4 2021 | $7,026,000 | -16.1% | 786,024 | +229.1% | 0.00% | – |
| Q3 2021 | $8,373,000 | +115.0% | 238,837 | +31.7% | 0.00% | – |
| Q2 2021 | $3,895,000 | +92.3% | 181,300 | +452.7% | 0.00% | – |
| Q1 2021 | $2,025,000 | – | 32,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |